CLNN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.10%

Insider Buying (Last 12 Months): $535,890.25

Insider Selling (Last 12 Months): $14,691.85

Clene Insider Trading History Chart

Clene Share Price & Price History

^$3.03

▼ -0.01 (-0.33%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Clene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2025	General Resonance Llc	Major Shareholder	Sell	1,333	$4.45	$5,931.85	712,252
9/30/2024	David J Matlin	Director	Buy	92,307	$4.75	$438,458.25	444,491
9/30/2024	Mark Mortenson	Insider	Buy	20,512	$4.75	$97,432.00	28,949
4/30/2024	General Resonance Llc	Major Shareholder	Sell	650	$8.40	$5,460.00	766,335
4/24/2024	General Resonance Llc	Major Shareholder	Sell	500	$6.60	$3,300.00	767,485
4/9/2024	General Resonance Llc	Major Shareholder	Sell	1,125	$7.80	$8,775.00	771,410
11/10/2023	David J Matlin	Director	Buy	12,500	$8.20	$102,500.00	352,184
6/26/2023	John Henry Stevens	Director	Buy	15,822	$16.00	$253,152.00	40,010
6/26/2023	Robert Dee Etherington	CEO	Buy	1,250	$16.20	$20,250.00	1,250
6/16/2023	David J Matlin	Director	Buy	75,000	$16.00	$1,200,000.00	339,684
11/2/2022	David J Matlin	Director	Buy	143,564	$20.20	$2,899,992.80	264,684
8/17/2022	John Henry Stevens	Director	Buy	2,383	$77.00	$183,491.00	16,761
7/18/2022	Robert Dee Etherington	CEO	Sell	1,174	$94.40	$110,825.60	2,829
6/17/2022	David J Matlin	Director	Buy	3,730	$50.20	$187,246.00	121,119
6/15/2022	Alison Mosca	Director	Buy	250	$52.40	$13,100.00	1,973
6/13/2022	David J Matlin	Director	Buy	2,750	$61.20	$168,300.00	108,838
6/6/2022	David J Matlin	Director	Buy	2,533	$51.40	$130,196.20	106,088
6/3/2022	David J Matlin	Director	Buy	500	$49.20	$24,600.00	103,555
5/27/2022	David J Matlin	Director	Buy	1,750	$45.40	$79,450.00	103,055
5/16/2022	General Resonance Llc	Major Shareholder	Sell	9,090	$44.00	$399,960.00	778,010
5/16/2022	Jonathon Gay	Director	Buy	500	$41.60	$20,800.00	3,437
5/16/2022	Robert Glanzman	Insider	Sell	235	$40.60	$9,541.00	528
4/20/2022	David J Matlin	Director	Buy	6,644	$60.20	$399,968.80	92,214

See Full Table

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

23.28% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Clene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Fullcircle Wealth LLC	13,023	$69K	0.0%	N/A	0.156%
2/13/2025	Renaissance Technologies LLC	18,040	$96K	0.0%	N/A	0.217%
2/12/2025	Geode Capital Management LLC	65,112	$0.35M	0.0%	+52.9%	0.782%
2/6/2025	SBI Securities Co. Ltd.	13,025	$69K	0.0%	N/A	0.158%
1/22/2025	Parsons Capital Management Inc. RI	36,500	$0.19M	0.0%	N/A	0.437%
10/24/2024	Lunt Capital Management Inc.	29,540	$0.14M	0.1%	-95.0%	0.431%
10/21/2024	Castleview Partners LLC	12,783	$59K	0.0%	N/A	0.186%
7/10/2024	Csenge Advisory Group	269,600	$96K	0.0%	+131.2%	0.210%
1/26/2024	Soltis Investment Advisors LLC	109,517	$32K	0.0%	-50.0%	0.085%
11/15/2023	Worth Venture Partners LLC	1,404,284	$0.70M	0.4%	-5.3%	1.094%
11/15/2023	Kepos Capital LP	131,322	$65K	0.0%	-22.8%	0.102%
11/13/2023	Silverarc Capital Management LLC	500,000	$0.25M	0.1%	+100.0%	0.389%
11/13/2023	AIGH Capital Management LLC	5,801,878	$2.88M	1.4%	-2.3%	4.518%
11/8/2023	Vivo Capital LLC	2,645,338	$1.40M	0.2%	-41.5%	2.060%
11/1/2023	Csenge Advisory Group	116,600	$58K	0.0%	N/A	0.091%
10/11/2023	AE Wealth Management LLC	172,528	$86K	0.0%	+208.5%	0.134%
8/15/2023	Silverarc Capital Management LLC	250,000	$0.22M	0.1%	N/A	0.319%
8/11/2023	AWM Investment Company Inc.	5,000,000	$4.40M	0.6%	N/A	6.378%
7/17/2023	Impact Partnership Wealth LLC	55,928	$49K	0.0%	N/A	0.071%
7/10/2023	AE Wealth Management LLC	55,928	$49K	0.0%	N/A	0.071%
5/10/2023	Condor Capital Management	165,836	$0.19M	0.0%	N/A	0.214%
2/13/2023	Kepos Capital LP	344,427	$0.34M	0.0%	-13.9%	0.467%
11/15/2022	Tang Capital Management LLC	1,100,000	$3.08M	0.4%	N/A	1.490%
11/15/2022	Kepos Capital LP	400,000	$1.12M	0.1%	-33.3%	0.542%
10/21/2022	Morgan Jess S & Co. Inc.	112,000	$0.31M	0.3%	+28.4%	0.176%
8/12/2022	Ikarian Capital LLC	70,000	$0.18M	0.0%	-86.4%	0.111%
8/8/2022	Oppenheimer & Co. Inc.	32,026	$81K	0.0%	+27.2%	0.051%
5/16/2022	Morgan Jess S & Co. Inc.	87,250	$0.34M	0.3%	+193.3%	0.138%
5/11/2022	Veritable L.P.	20,000	$79K	0.0%	N/A	0.032%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	241,737	$0.95M	0.0%	-3.4%	0.382%
5/2/2022	Allspring Global Investments Holdings LLC	32,129	$0.13M	0.0%	N/A	0.051%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	250,235	$1.11M	0.0%	N/A	0.402%
2/2/2022	Oppenheimer & Co. Inc.	22,214	$91K	0.0%	N/A	0.036%
11/15/2021	Penserra Capital Management LLC	5,154	$35K	0.0%	-35.9%	0.008%
11/12/2021	Laird Norton Trust Company LLC	268,581	$1.83M	0.2%	+7.6%	0.437%
11/12/2021	Geode Capital Management LLC	405,737	$2.77M	0.0%	+0.8%	0.660%
11/9/2021	Morgan Jess S & Co. Inc.	29,750	$0.20M	0.1%	N/A	0.048%
11/9/2021	BlackRock Inc.	1,065,726	$7.28M	0.0%	-9.5%	1.733%
11/9/2021	Soltis Investment Advisors LLC	218,920	$1.50M	0.2%	N/A	0.356%
11/4/2021	Deutsche Bank AG	11,284	$77K	0.0%	-16.9%	0.018%
11/2/2021	New York State Common Retirement Fund	12,560	$86K	0.0%	-35.9%	0.020%
8/17/2021	Boothbay Fund Management LLC	13,276	$0.15M	0.0%	-21.6%	0.022%
8/16/2021	California State Teachers Retirement System	31,590	$0.36M	0.0%	N/A	0.051%
8/16/2021	Pinz Capital Management LP	6,292	$71K	0.0%	N/A	0.010%
8/16/2021	Charles Schwab Investment Management Inc.	147,392	$1.66M	0.0%	+53.0%	0.240%
8/16/2021	State Street Corp	278,619	$3.13M	0.0%	N/A	0.453%
8/16/2021	Nuveen Asset Management LLC	54,870	$0.62M	0.0%	N/A	0.089%
8/13/2021	Northern Trust Corp	82,770	$0.93M	0.0%	+105.7%	0.135%
8/13/2021	Geode Capital Management LLC	402,395	$4.52M	0.0%	+82.6%	0.655%
8/13/2021	Vanguard Group Inc.	1,132,082	$12.73M	0.0%	+9.3%	1.844%
8/12/2021	Kepos Capital LP	550,000	$6.18M	0.5%	+175.0%	0.896%
8/12/2021	Penserra Capital Management LLC	8,043	$90K	0.0%	+37.7%	0.013%
8/12/2021	State of Wisconsin Investment Board	15,626	$0.18M	0.0%	N/A	0.025%
8/12/2021	Legal & General Group Plc	2,223	$25K	0.0%	N/A	0.004%
8/12/2021	JPMorgan Chase & Co.	8,785	$99K	0.0%	N/A	0.014%
8/12/2021	The Manufacturers Life Insurance Company	13,393	$0.15M	0.0%	N/A	0.022%
8/11/2021	Bank of New York Mellon Corp	57,228	$0.64M	0.0%	N/A	0.093%
8/11/2021	BlackRock Inc.	1,177,265	$13.23M	0.0%	+2,071.4%	1.918%
8/11/2021	Deutsche Bank AG	13,585	$0.15M	0.0%	N/A	0.022%
8/5/2021	Rhumbline Advisers	15,031	$0.17M	0.0%	N/A	0.024%
8/2/2021	New York State Common Retirement Fund	19,600	$0.22M	0.0%	N/A	0.032%
8/2/2021	SRS Capital Advisors Inc.	52,250	$0.59M	0.1%	N/A	0.085%
8/2/2021	Advisor Group Holdings Inc.	5,000	$56K	0.0%	N/A	0.008%
5/19/2021	Squarepoint Ops LLC	30,676	$0.39M	0.0%	N/A	0.051%
5/18/2021	Millennium Management LLC	130,068	$1.66M	0.0%	N/A	0.218%
5/18/2021	Citadel Advisors LLC	46,163	$0.59M	0.0%	N/A	0.077%
5/17/2021	Ikarian Capital LLC	118,533	$1.52M	0.1%	N/A	0.199%
5/17/2021	Goldman Sachs Group Inc.	13,593	$0.17M	0.0%	N/A	0.023%
5/13/2021	Laird Norton Trust Company LLC	249,561	$3.19M	0.4%	N/A	0.419%
5/13/2021	Penserra Capital Management LLC	5,840	$74K	0.0%	N/A	0.010%
5/13/2021	Kepos Capital LP	200,000	$2.56M	0.2%	-24.0%	0.336%
5/13/2021	Citigroup Inc.	10,646	$0.14M	0.0%	N/A	0.018%
5/12/2021	Northern Trust Corp	40,246	$0.51M	0.0%	N/A	0.068%
5/12/2021	Geode Capital Management LLC	220,355	$2.82M	0.0%	N/A	0.370%
5/7/2021	BlackRock Inc.	54,217	$0.69M	0.0%	N/A	0.091%
4/27/2021	Harel Insurance Investments & Financial Services Ltd.	34,911	$1.49M	0.0%	N/A	1.010%

Data available starting January 2016

See Full Table

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Today's Range

Now: $3.03

$2.98

$3.15

50 Day Range

MA: $4.00

$2.58

$4.90

52 Week Range

Now: $3.03

$2.57

$9.20

Volume

14,339 shs

Average Volume

79,417 shs

Market Capitalization

$26.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Who are the company insiders with the largest holdings of Clene?: Clene's top insider shareholders include:
General Resonance Llc (Major Shareholder)
David J Matlin (Director)
John Henry Stevens (Director)
Mark Mortenson (Insider)
Robert Dee Etherington (CEO)
Learn More about top insider investors at Clene.